Viewing StudyNCT00036400



Ignite Creation Date: 2024-05-05 @ 11:25 AM
Last Modification Date: 2024-10-26 @ 9:07 AM
Study NCT ID: NCT00036400
Status: COMPLETED
Last Update Posted: 2011-06-10
First Post: 2002-05-09

Brief Title: Study of the Efficacy and Safety of Epoetin Alfa Administered Weekly in Patients With Gastric or Rectal Cancers Undergoing a Treatment Plan of Preoperative Chemotherapy and Radiation Therapy Followed by Surgery
Sponsor: Johnson Johnson Pharmaceutical Research Development LLC
Organization: Johnson Johnson Pharmaceutical Research Development LLC

Organization Data

Organization: Johnson Johnson Pharmaceutical Research Development LLC
Class: INDUSTRY
Study ID: CR002365
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Johnson Johnson Pharmaceutical Research Development LLC
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Ortho Biotech Products LP INDUSTRY